DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Mukherjee S, Ibrahimi S, Machiorlatti M. et al.
Personalized dosing versus fixed dosing of immune checkpoint inhibitors: a cost analysis study.
Am J Ther 2018;
25 (06) e767-e768
We do not assume any responsibility for the contents of the web pages of other providers.